|
1
|
Bleyer A, Barr R, Hayes-Lattin B, Thomas
D, Ellis C and Anderson B: Biology and The distinctive biology of
cancer in adolescents and young adults. Nat Rev Cancer. 8:288–298.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taylor R, Knowles HJ and Athanasou NA:
Ewing sarcoma cells express RANKL and support osteoclastogenesis. J
Pathol. 225:195–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paulussen M, Craft AW, Lewis I, Hackshaw
A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C,
et al; European Intergroup Cooperative Ewing's Sarcoma Study-92.
Results of the EICESS-92 Study: Two randomized trials of Ewing's
sarcoma treatment - cyclophosphamide compared with ifosfamide in
standard-risk patients and assessment of benefit of etoposide added
to standard treatment in high-risk patients. J Clin Oncol.
26:4385–4393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ladenstein R, Pötschger U, Le Deley MC,
Whelan J, Paulussen M, Oberlin O, van den Berg H, Dirksen U, Hjorth
L, Michon J, et al: Primary disseminated multifocal Ewing sarcoma:
Results of the Euro-EWING 99 trial. J Clin Oncol. 28:3284–3291.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meltzer PS: Cancer genomics: Small RNAs
with big impacts. Nature. 435:745–746. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Zhang H, Zhao M, Lv Z, Zhang X,
Qin X, Wang H, Wang S, Su J, Lv X, et al: MiR-138 inhibits tumor
growth through repression of EZH2 in non-small cell lung cancer.
Cell Physiol Biochem. 31:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu C, Fu H, Gao L, Wang L, Wang W, Li J,
Li Y, Dou L, Gao X, Luo X, et al: BCR-ABL/GATA1/miR-138 mini
circuitry contributes to the leukemogenesis of chronic myeloid
leukemia. Oncogene. 33:44–54. 2014. View Article : Google Scholar
|
|
11
|
Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K,
Wu M, Liang Y, Liu P, Tang J, et al: MiR-138 suppressed
nasopharyngeal carcinoma growth and tumorigenesis by targeting the
CCND1 oncogene. Cell Cycle. 11:2495–2506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kohlhoff J and Barnett B: Parenting
self-efficacy: Links with maternal depression, infant behaviour and
adult attachment. Early Hum Dev. 89:249–256. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schlaepfer DD and Mitra SK: Multiple
connections link FAK to cell motility and invasion. Curr Opin Genet
Dev. 14:92–101. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Siesser PM and Hanks SK: The signaling and
biological implications of FAK overexpression in cancer. Clin
Cancer Res. 12:3233–3237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McLean GW, Carragher NO, Avizienyte E,
Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase
in cancer - a new therapeutic opportunity. Nat Rev Cancer.
5:505–515. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lahlou H, Sanguin-Gendreau V, Zuo D,
Cardiff RD, McLean GW, Frame MC and Muller WJ: Mammary
epithelial-specific disruption of the focal adhesion kinase blocks
mammary tumor progression. Proc Natl Acad Sci USA. 104:20302–20307.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W,
Wu Z, Chen T, Wu W, Lobie PE, et al: MicroRNA-7 inhibits
epithelial-to-mesenchymal transition and metastasis of breast
cancer cells via targeting FAK expression. PLoS One. 7:e415232012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song J, Kim D and Jin EJ: MicroRNA-488
suppresses cell migration through modulation of the focal adhesion
activity during chondrogenic differentiation of chick limb
mesenchymal cells. Cell Biol Int. 35:179–185. 2011. View Article : Google Scholar
|
|
19
|
Luedde T: MicroRNA-151 and its hosting
gene FAK (focal adhesion kinase) regulate tumor cell migration and
spreading of hepatocellular carcinoma. Hepatology. 52:1164–1166.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lujambio A and Esteller M: How epigenetics
can explain human metastasis: A new role for microRNAs. Cell Cycle.
8:377–382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Medina PP and Slack FJ: microRNAs and
cancer: An overview. Cell Cycle. 7:2485–2492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT:
MiR-138 induces cell cycle arrest by targeting cyclin D3 in
hepatocellular carcinoma. Carcinogenesis. 33:1113–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee YC, Tzeng WF, Chiou TJ and Chu ST:
MicroRNA-138 suppresses neutrophil gelatinase-associated lipocalin
expression and inhibits tumorigenicity. PLoS One. 7:e529792012.
View Article : Google Scholar
|
|
24
|
Schlaepfer DD, Hauck CR and Sieg DJ:
Signaling through focal adhesion kinase. Prog Biophys Mol Biol.
71:435–478. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carelli S, Zadra G, Vaira V, Falleni M,
Bottiglieri L, Nosotti M, Di Giulio AM, Gorio A and Bosari S:
Up-regulation of focal adhesion kinase in non-small cell lung
cancer. Lung Cancer. 53:263–271. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siejka A, Barabutis N and Schally AV: GHRH
antagonist inhibits focal adhesion kinase (FAK) and decreases
expression of vascular endothelial growth factor (VEGF) in human
lung cancer cells in vitro. Peptides. 37:63–68. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Golubovskaya VM, Sumbler B, Ho B, Yemma M
and Cance WG: MiR-138 and MiR-135 directly target focal adhesion
kinase, inhibit cell invasion, and increase sensitivity to
chemotherapy in cancer cells. Anticancer Agents Med Chem. 14:18–28.
2014. View Article : Google Scholar :
|
|
28
|
Nowicki TS, Zhao H, Darzynkiewicz Z,
Moscatello A, Shin E, Schantz S, Tiwari RK and Geliebter J:
Downregulation of uPAR inhibits migration, invasion, proliferation,
FAK/PI3K/Akt signaling and induces senescence in papillary thyroid
carcinoma cells. Cell Cycle. 10:100–107. 2011. View Article : Google Scholar :
|
|
29
|
Li LH, Zheng MH, Luo Q, Ye Q, Feng B, Lu
AG, Wang ML, Chen XH, Su LP and Liu BY: P21-activated protein
kinase 1 induces colorectal cancer metastasis involving ERK
activation and phosphorylation of FAK at Ser-910. Int J Oncol.
37:951–962. 2010.PubMed/NCBI
|
|
30
|
Jia YL, Shi L, Zhou JN, Fu CJ, Chen L,
Yuan HF, Wang YF, Yan XL, Xu YC, Zeng Q, et al: Epimorphin promotes
human hepatocellular carcinoma invasion and metastasis through
activation of focal adhesion kinase/extracellular signal-regulated
kinase/matrix metalloproteinase-9 axis. Hepatology. 54:1808–1818.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan H, Zhao X, Sun S, Luo M and Guan JL:
Function of focal adhesion kinase scaffolding to mediate endophilin
A2 phos-phorylation promotes epithelial-mesenchymal transition and
mammary cancer stem cell activities in vivo. J Biol Chem.
288:3322–3333. 2013. View Article : Google Scholar :
|
